checkAd

     117  0 Kommentare Itamar Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence - Seite 2

    The study will be conducted in four phases that include data acquisition; extracting appropriate study populations for each healthcare outcome evaluated; baseline modeling using electronic medical record (EMR) data and published literature; and WatchPAT signal modeling using artificial intelligence and machine learning to integrate WatchPAT signal data and EMR data. The study is anticipated to take two years.

    “Signal processing can capture 'hidden' objective features connected to a variety of diseases. We are excited to evaluate its potential to predict a wide array of cardiovascular diseases. If the model will prove itself; it will be a huge potential to expand this model globally to other healthcare systems especially in poor countries with no well-established EMR systems,” said Prof. Ran Balicer, the director of Clalit Research Institute.

    About Itamar Medical Ltd.

    Itamar Medical is engaged in research, development, sales and marketing of non-invasive medical devices for the diagnosis of respiratory sleep disorders and uses a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the cardiology market. The Company offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare costs. Its flagship PAT-based product, the WatchPAT device, is a home-use diagnostic device for sleep breathing disorders. Its digital health platform, including CloudPAT and SleePATh, facilitates seamless and complete care pathway management in a complex environment. It also offers the EndoPAT system, an FDA-cleared device to test endothelial dysfunction and to evaluate the risk of heart disease and other cardiovascular diseases. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit www.itamar-medical.com.

    About Clalit Health Services

    Clalit Health Services is the largest healthcare organization in Israel, providing primary, specialty and hospital care to over 50% of the Israeli population, with minimal attrition throughout members life. Clalit has been a global forerunner in digital health innovation and at-scale implementation, and utilized for this purpose its unique database which holds over 20 years of payer and provider detailed EHR data. The Clalit Research Institute is a globally recognized innovation center for data science in healthcare., responsible for integrating data and knowhow into innovative digital health tools and insights, with an aim to promote proactive, predictive, and precise care in daily practice.

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Itamar Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence - Seite 2 Study will evaluate how raw signals from tens of thousands of WatchPAT recordings conducted over the last 10 years in combination with health medical records can be leveraged to predict cardiovascular outcomes CAESAREA, Israel, March 02, 2020 …